246 related articles for article (PubMed ID: 37648741)
1. Effect of aspirin on incidence, recurrence, and mortality in prostate cancer patients: integrating evidence from randomized controlled trials and real-world studies.
Ma S; Xia W; Wu B; Sun C; Jiang Y; Liu H; Lowe S; Zhou Z; Xie P; Gao J; Feng L; Guo X; Qu G; Sun Y
Eur J Clin Pharmacol; 2023 Nov; 79(11):1475-1503. PubMed ID: 37648741
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
Liu Y; Chen JQ; Xie L; Wang J; Li T; He Y; Gao Y; Qin X; Li S
BMC Med; 2014 Mar; 12():55. PubMed ID: 24678716
[TBL] [Abstract][Full Text] [Related]
4. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
[TBL] [Abstract][Full Text] [Related]
5. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies.
Islami F; Moreira DM; Boffetta P; Freedland SJ
Eur Urol; 2014 Dec; 66(6):1054-64. PubMed ID: 25242554
[TBL] [Abstract][Full Text] [Related]
7. Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology.
Campi R; Brookman-May SD; Subiela Henríquez JD; Akdoğan B; Brausi M; Klatte T; Langenhuijsen JF; Linares-Espinos E; Marszalek M; Roupret M; Stief CG; Volpe A; Minervini A; Rodriguez-Faba O
Eur Urol Focus; 2019 Nov; 5(6):1029-1057. PubMed ID: 29661588
[TBL] [Abstract][Full Text] [Related]
8. Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis.
Fan LL; Xie CP; Wu YM; Gu XJ; Chen YH; Wang YJ
Biomed Res Int; 2019; 2019():9379602. PubMed ID: 31073532
[TBL] [Abstract][Full Text] [Related]
9. Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau).
Prause LW; Manka L; Millan C; Lang E; Wyler SF; Grobholz R; Hammerer-Lercher A; Sulser T; Recker F; Kwiatkowski M; Eberli D
World J Urol; 2020 Oct; 38(10):2485-2491. PubMed ID: 31865534
[TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer.
Ilic D; Neuberger MM; Djulbegovic M; Dahm P
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
[TBL] [Abstract][Full Text] [Related]
11. Does aspirin reduce the incidence, recurrence, and mortality of colorectal cancer? A meta-analysis of randomized clinical trials.
Ma S; Han T; Sun C; Cheng C; Zhang H; Qu G; Bhan C; Yang H; Guo Z; Yan Y; Cao C; Ji Z; Zhou Q
Int J Colorectal Dis; 2021 Aug; 36(8):1653-1666. PubMed ID: 33594505
[TBL] [Abstract][Full Text] [Related]
12. Does aspirin have an effect on risk of death in patients with COVID-19? A meta-analysis.
Ma S; Su W; Sun C; Lowe S; Zhou Z; Liu H; Qu G; Xia W; Xie P; Wu B; Gao J; Feng L; Sun Y
Eur J Clin Pharmacol; 2022 Sep; 78(9):1403-1420. PubMed ID: 35732963
[TBL] [Abstract][Full Text] [Related]
13. Effect of physical activity on incidence and mortality in patients with gastric cancer: evidence from real-world studies.
Ma S; Liu H; Sun C; Meng M; Qu G; Jiang Y; Wu B; Gao J; Feng L; Xie P; Xia W; Sun Y
Cancer Causes Control; 2023 Dec; 34(12):1095-1111. PubMed ID: 37491662
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Use and Common Cancer Risk: A Meta-Analysis of Cohort Studies and Randomized Controlled Trials.
Wang L; Zhang R; Yu L; Xiao J; Zhou X; Li X; Song P; Li X
Front Oncol; 2021; 11():690219. PubMed ID: 34277434
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
